No matter your personal opinions, it will be funds that lift this or let it sink. The broker data linked in the charting thread tells a story worth paying attention to. The coming weeks management will be attending investor events as they mentioned and the weeks following will be where the short and near term direction stands.
As it stands, the bottom line metrics in the actual report will not satisfy the average growth investor template. Looking past that and into the future is the tricky part of course.
Question re. the hernia product: I am pretty sure that 2022 is the expected year for deployment if I heard correctly - is this new information?
Ann: FY20 Results Webcast, page-126
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.35 |
Change
0.020(0.86%) |
Mkt cap ! $1.622B | |||
| Open | High | Low | Value | Volume |
| $2.37 | $2.40 | $2.34 | $2.822M | 1.196M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13436 | $2.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.36 | 11159 | 4 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |